Boca Raton City Online – Lifestyle
Author:
CITIUS PHARMACEUTICALS, INC./Irth Communications
Citius Pharmaceuticals Announces Closing of Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules
April 24, 2026
Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules
April 24, 2026
Citius Pharmaceuticals, Inc. Secures $3.8 million through New Jersey Economic Development Program
March 7, 2026
Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™
March 6, 2026